In the murine model of obesity-related asthma, exogenous administration of adiponectin led to a reduction in airway resistance, oxidative stress, and inflammatory reaction in lung tissue, confirming that adiponectin contributes substantially to the asthma–obesity phenotype [115]. Here, ADIPOQ is linked to obesity disorder.